{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:02:27Z","timestamp":1791489747424,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,2]],"date-time":"2018-12-02T00:00:00Z","timestamp":1543708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2018ZX09201001-001-001"],"award-info":[{"award-number":["2018ZX09201001-001-001"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013314","name":"Higher Education Discipline Innovation Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773957"],"award-info":[{"award-number":["81773957"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.biopha.2018.12.003","type":"journal-article","created":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T23:44:19Z","timestamp":1544226259000},"page":"571-581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Novel hepatoprotective role of Leonurine hydrochloride against experimental non-alcoholic steatohepatitis mediated via AMPK\/SREBP1 signaling pathway"],"prefix":"10.1016","volume":"110","author":[{"given":"Li","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu-Si","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhan Ullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Rong","family":"Qi-Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2018.12.003_bib0005","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ncpgasthep0084","article-title":"Mechanisms of disease: pathogenesis of nonalcoholic fatty liver disease","volume":"2","author":"Sanyal","year":"2005","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.biopha.2018.12.003_bib0010","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jhep.2011.10.027","article-title":"Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace","volume":"56","author":"Baffy","year":"2012","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2018.12.003_bib0015","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jhep.2010.04.008","article-title":"A position statement on NAFLD\/NASH based on the EASL 2009 special conference","volume":"53","author":"Ratziu","year":"2010","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.biopha.2018.12.003_bib0020","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrgastro.2013.34","article-title":"NAFLD in Asia-as common and important as in the west","volume":"10","author":"Farrell","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.biopha.2018.12.003_bib0025","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/MCG.0000000000000116","article-title":"World gastroenterology organisation global guidelines: nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"48","author":"LaBrecque","year":"2014","journal-title":"J. Clin. Gastroenterol."},{"issue":"2","key":"10.1016\/j.biopha.2018.12.003_bib0030","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/ncpgasthep0055","article-title":"Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications","volume":"1","author":"Friedman","year":"2004","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2018.12.003_bib0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000443344","article-title":"Clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"9","author":"EASL-EASD-EASO","year":"2016","journal-title":"Obes. Facts"},{"issue":"7","key":"10.1016\/j.biopha.2018.12.003_bib0040","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1440-1681.2008.05135.x","article-title":"Protective effects of leonurine in neonatal rat hypoxic cardiomyocytes and rat infarcted heart","volume":"36","author":"Liu","year":"2009","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2018.12.003_bib0045","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.intimp.2015.02.023","article-title":"Leonurine ameliorates kidney fibrosis via suppressing TGF-beta and NF-kappaB signaling pathway in UUO mice","volume":"25","author":"Cheng","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2018.12.003_bib0050","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.atherosclerosis.2011.04.027","article-title":"Leonurine protects against tumor necrosis factor-alpha-mediated inflammation in human umbilical vein endothelial cells","volume":"222","author":"Liu","year":"2012","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.biopha.2018.12.003_bib0055","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2174\/138920110793262015","article-title":"Antiapoptotic effect of novel compound from Herba leonuri - leonurine (SCM-198): a mechanism through inhibition of mitochondria dysfunction in H9c2 cells","volume":"11","author":"Liu","year":"2010","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"1","key":"10.1016\/j.biopha.2018.12.003_bib0060","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.atherosclerosis.2012.06.066","article-title":"SCM-198 attenuates early atherosclerotic lesions in hypercholesterolemic rabbits via modulation of the inflammatory and oxidative stress pathways","volume":"224","author":"Zhang","year":"2012","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.biopha.2018.12.003_bib0065","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1159\/000484031","article-title":"Leonurine prevents atherosclerosis via promoting the expression of ABCA1 and ABCG1 in a ppargamma\/lxralpha signaling pathway-dependent manner","volume":"43","author":"Jiang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"17","key":"10.1016\/j.biopha.2018.12.003_bib0070","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.7150\/thno.21400","article-title":"Pro-inflammatory CXCR3 impairs mitochondrial function in experimental non-alcoholic steatohepatitis","volume":"7","author":"Du","year":"2017","journal-title":"Theranostics"},{"issue":"18","key":"10.1016\/j.biopha.2018.12.003_bib0075","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1021\/acs.jmedchem.7b00398","article-title":"A dual modulator of farnesoid X receptor and soluble epoxide hydrolase to counter nonalcoholic steatohepatitis","volume":"60","author":"Schmidt","year":"2017","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2018.12.003_bib0080","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1745-7254.2008.00807.x","article-title":"Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase","volume":"29","author":"Shang","year":"2008","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2018.12.003_bib0085","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.biopha.2018.03.170","article-title":"Triterpenic acids-enriched fraction from Cyclocarya paliurus attenuates non-alcoholic fatty liver disease via improving oxidative stress and mitochondrial dysfunction","volume":"104","author":"Zhao","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2018.12.003_bib0090","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejphar.2016.06.040","article-title":"(S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation","volume":"788","author":"Park","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2018.12.003_bib0095","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jhep.2018.01.035","article-title":"Prolactin improves hepatic steatosis via CD36 pathway","volume":"68","author":"Zhang","year":"2018","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2018.12.003_bib0100","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1038\/s41598-018-22339-0","article-title":"Celecoxib alleviates nonalcoholic fatty liver disease by restoring autophagic flux","volume":"8","author":"Liu","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2018.12.003_bib0105","doi-asserted-by":"crossref","first-page":"H794","DOI":"10.1111\/1750-3841.13210","article-title":"Effects of long-chain and medium-chain fatty acids on apoptosis and oxidative stress in human liver cells with steatosis","volume":"81","author":"Wang","year":"2016","journal-title":"J. Food Sci."},{"issue":"3","key":"10.1016\/j.biopha.2018.12.003_bib0110","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3109\/09637486.2016.1153611","article-title":"Medium-chain fatty acid reduces lipid accumulation by regulating expression of lipid-sensing genes in human liver cells with steatosis","volume":"67","author":"Wang","year":"2016","journal-title":"Int. J. Food Sci. Nutr."},{"issue":"1","key":"10.1016\/j.biopha.2018.12.003_bib0115","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/s41598-017-01435-7","article-title":"Simultaneous quantification of amino metabolites in multiple metabolic pathways using ultra-high performance liquid chromatography with tandem-mass spectrometry","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2018.12.003_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4093\/dmj.2016.40.1.1","article-title":"Novel molecular mechanisms in the development of non-alcoholic steatohepatitis","volume":"40","author":"Povero","year":"2016","journal-title":"Diabetes Metab. J."},{"issue":"2","key":"10.1016\/j.biopha.2018.12.003_bib0125","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmed.2007.12.003","article-title":"Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis","volume":"14","author":"Marra","year":"2008","journal-title":"Trends Mol. Med."},{"issue":"11","key":"10.1016\/j.biopha.2018.12.003_bib0130","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.bbalip.2014.08.015","article-title":"Role of white adipose lipolysis in the development of NASH induced by methionine- and choline-deficient diet","volume":"1841","author":"Tanaka","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"Suppl. 4","key":"10.1016\/j.biopha.2018.12.003_bib0135","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1038\/ijo.2008.116","article-title":"AMPK: a key regulator of energy balance in the single cell and the whole organism","volume":"32","author":"Hardie","year":"2008","journal-title":"Int. J. Obes. (Lond.)"},{"issue":"9","key":"10.1016\/j.biopha.2018.12.003_bib0140","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.2527\/jas.2011-4403","article-title":"Amount and source of dietary copper affects small intestine morphology, duodenal lipid peroxidation, hepatic oxidative stress,and mRNA expression of hepatic copper regulatory proteins in weanling pigs","volume":"90","author":"Fry","year":"2012","journal-title":"J. Anim. Sci."},{"key":"10.1016\/j.biopha.2018.12.003_bib0145","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.fct.2013.07.008","article-title":"Glutathione defense mechanism in liver injury: insights from animal models","volume":"60","author":"Chen","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.biopha.2018.12.003_bib0150","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/jhep.2003.50307","article-title":"Central role of PPAR_-dependent hepatic lipid turnover in dietary steatohepatitis in mice","volume":"38","author":"Ip","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2018.12.003_bib0155","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jhep.2016.05.005","article-title":"A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer","volume":"65","author":"Asgharpour","year":"2016","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.biopha.2018.12.003_bib0160","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/hep.20170","article-title":"Administration of the Potent PPAR_ Agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice","volume":"39","author":"Ip","year":"2004","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.biopha.2018.12.003_bib0165","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: a nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.biopha.2018.12.003_bib0170","article-title":"AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes","volume":"277","author":"Winder","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.biopha.2018.12.003_bib0175","doi-asserted-by":"crossref","first-page":"H895","DOI":"10.1152\/ajpheart.00137.2011","article-title":"Acute rosiglitazone treatment is cardioprotective against ischemiareperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice","volume":"301","author":"Morrison","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2018.12.003_bib0180","doi-asserted-by":"crossref","first-page":"E730","DOI":"10.1152\/ajpendo.00225.2016","article-title":"Treatment of non-alcoholic fatty liver disease (NAFLD): role of AMPK","volume":"311","author":"Smith","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"Suppl","key":"10.1016\/j.biopha.2018.12.003_bib0185","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1194\/jlr.R800053-JLR200","article-title":"Coleman RA: Hepatic triacylglycerol accumulation and insulin resistance","volume":"50","author":"Nagle","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2018.12.003_bib0190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1388-1981(00)00140-2","article-title":"Regulation of gene expression by SREBP and SCAP","volume":"1529","author":"Edwards","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2018.12.003_bib0195","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1194\/jlr.M700033-JLR200","article-title":"SREBP-1-independent regulation of lipogenic gene expression in adipocytes","volume":"48","author":"Sekiya","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2018.12.003_bib0200","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","article-title":"AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice","volume":"13","author":"Li","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2018.12.003_bib0205","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4196\/kjpp.2009.13.6.449","article-title":"Overexpression of AMPKalpha1 ameliorates fatty liver in hyperlipidemic diabetic rats","volume":"13","author":"Seo","year":"2009","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2018.12.003_bib0210","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1053\/j.gastro.2004.09.049","article-title":"The role of AMP-activated protein kinase in the action of ethanol in theliver","volume":"127","author":"You","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2018.12.003_bib0215","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/jcb.22024","article-title":"AMP-activated protein kinase suppresses LXR-dependent sterol regulatory element-binding protein-1c transcription in rat hepatoma McA-RH7777 cells","volume":"106","author":"Yang","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biopha.2018.12.003_bib0220","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2018.12.003_bib0225","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1161\/CIRCRESAHA.108.190918","article-title":"Activation of AMPactivated protein kinase by metformin improves left ventricular function and survival in heart failure","volume":"104","author":"Gundewar","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2018.12.003_bib0230","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1161\/CIRCULATIONAHA.108.798561","article-title":"Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase","volume":"119","author":"Sasaki","year":"2009","journal-title":"Circulation"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218367994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218367994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T21:21:45Z","timestamp":1764105705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218367994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":46,"alternative-id":["S0753332218367994"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.12.003","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel hepatoprotective role of Leonurine hydrochloride against experimental non-alcoholic steatohepatitis mediated via AMPK\/SREBP1 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}